Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S2214-109X(21)00180-7 http://scihub22266oqcxt.onion/10.1016/S2214-109X(21)00180-7 33961810!8096324!33961810     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33961810&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Lancet+Glob+Health 2021 ; 9 (8): e1169-e1171 Nephropedia Template TP {{tp|p=33961810|t=2021. Time for the ethical management of COVID-19 vaccines |pdf=|usr=}}{{33961810}} gab.com Text Time for the ethical management of COVID-19 vaccines JO: Lancet Glob Health http://www.kidney.de/pget.php?&tw=1&pmid=33961810 #FOAvip The ethical distribution of life-saving medical and public health interventions to vulnerable groups has often been overlooked. Valuation of life linked to an individual's country of origin, the pharmaceutical industry's prioritisation of profit, the exploitation of vulnerable groups in clinical trials, and the resulting hesitancy towards drugs and vaccines have, among other factors, made the human right to health unattainable for many people. The COVID-19 pandemic presents itself as an opportunity to reverse this long-standing trajectory of unethical practices in global health. By ensuring the ethical inclusion of vulnerable groups in the vaccine development process and making a safe, effective vaccine accessible to all, pharmaceutical companies, governments, and international organisations can usher in a new era of global health that relies solely on ethical decision making. Twit Text FOAVip Time for the ethical management of COVID-19 vaccines ????Lancet Glob Health http://www.kidney.de/pget.php?&tw=1&pmid=33961810 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33961810 #FOAvip English Wikipedia <ref>{{Cite pmid|33961810}}</ref> Time for the ethical management of COVID-19 vaccines #MMPMID33961810 Binagwaho A; Mathewos K; Davis S Lancet Glob Health 2021[Aug]; 9 (8): e1169-e1171 PMID33961810show ga The ethical distribution of life-saving medical and public health interventions to vulnerable groups has often been overlooked. Valuation of life linked to an individual's country of origin, the pharmaceutical industry's prioritisation of profit, the exploitation of vulnerable groups in clinical trials, and the resulting hesitancy towards drugs and vaccines have, among other factors, made the human right to health unattainable for many people. The COVID-19 pandemic presents itself as an opportunity to reverse this long-standing trajectory of unethical practices in global health. By ensuring the ethical inclusion of vulnerable groups in the vaccine development process and making a safe, effective vaccine accessible to all, pharmaceutical companies, governments, and international organisations can usher in a new era of global health that relies solely on ethical decision making. |*COVID-19 Vaccines[MESH] |COVID-19/epidemiology/*prevention & control[MESH] |Global Health/*ethics[MESH] |Health Care Rationing/*ethics[MESH] |Humans[MESH] |Public Health/*ethics[MESH]Time for the ethical management of COVID-19 vaccines (epmc).pdf DeepDyve Pubget Overpricing